HomeOpen Access NewsPharma

Pharma

Subscribe to Updates

Over 3 Million children died from AMR-related infections in 2022

Pharma
A landmark study presented at ESCMID Global 2025 reveals the devastating impact of antimicrobial resistance (AMR) on children's health. In 2022, over 3 million children worldwide died from antibiotic-resistant infections, highlighting the urgent need for global action.

Benchmarking Regulatory systems governing veterinary medicines – part 2

Pharma
Rick Clayton, Technical Director, AnimalhealthEurope, in the second chapter of this three-part series, continues to examine Benchmarking Regulatory systems governing veterinary medicines.

Why COVID vaccine development was exceptionally speedy

Pharma
Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.

Countries denied access to vaccines they helped develop

Pharma
A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.

COVID-19 variant vaccines will be fast-tracked through cutting-edge testing centre

Pharma
Health Secretary Matt Hancock has announced that vaccines tailored to tackle COVID-19 variants will be fast-tracked through new state-of-the-art labs.

Combination of remdesivir and hep C drugs effective against COVID-19

Pharma
A combination of remdesivir and drugs for hepatitis C virus (HCV) have presented strong effectiveness against COVID-19 in a new study.

CBD oil for ADHD: What the research shows

Pharma
CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.

Cannabis as a treatment for COVID-19

Pharma
Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.

CBD Novel Foods in the UK

Pharma
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.

Benchmarking Regulatory systems governing veterinary medicines

Pharma
Rick Clayton, Technical Director, AnimalhealthEurope, unpacks Benchmarking Regulatory systems governing veterinary medicines in this the first of a series of three articles.

Pharmaceuticals: Falsified medicines

Pharma
Dr Ash Ramzan, Founder and Principal Consultant, Woodley BioReg Limited, turns the spotlight on falsified medicines in this pharmaceuticals focus.

Why are illegal pharma markets still prevalent today?

Pharma
Professor Luis Diestre discusses the research and findings of his European Research Council funded Illegal Pharma Project, focussing on the ever popular market for counterfeit pharmaceuticals.

Cannabidiol, skin homeostasis and acne

Pharma
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.

The UK’s legalisation of medicinal cannabis

Pharma
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.

COVID-19 and drugs in the European neighbourhood partnership countries

Pharma
The EU drugs agency explores the impact of COVID-19 on drug markets, use and services in the European neighbourhood partnership countries.

Medical cannabis in the UK and the industry’s future

Pharma
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.

Drug prices in the U.S. are 2.56 times higher

Pharma
Prescription drug prices in the United States are 2.56 times higher than in other countries, according to a new RAND Corporation report.
1...678...10Page 7 of 10

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd